Asset
OMECAMTIV MECARBIL
CYTOKINETICS INCORPORATED COMMON STOCK
Revenue
No revenue reported in loaded filings.
Clinical trials (13)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01380223 | phase1 | completed | 2005-08-01 | 2006-04-01 | Cytokinetics | A Pharmacokinetic and Pharmacodynamic Study of Omecamtiv Mecarbil in Healthy Volunteers |
| NCT00624442 | phase2 | completed | 2007-04-01 | 2009-02-01 | Cytokinetics | A Study of CK-1827452 Infusion in Stable Heart Failure |
| NCT04464525 | phase3 | withdrawn | 2020-12-18 | 2026-11-27 | Cytokinetics | Omecamtiv Mecarbil Post-trial Access Study |
| NCT00682565 | phase2 | completed | 2008-04-01 | 2008-11-01 | Cytokinetics | PK and Tolerability of IV and Oral CK-1827452 in Patients With Ischemic Cardiomyopathy and Angina |
| NCT01077167 | phase2 | withdrawn | 2010-07-01 | 2011-05-01 | Cytokinetics | Pharmacokinetic Study of Omecamtiv Mecarbil in Heart Failure Patients |
FDA applications (0)
This company has no applications containing this asset.